Arylsulphatase A Pseudodeficiency (ARSA-PD), hypertension and chronic renal disease in Aboriginal Australians.
Arylsulphatase A Pseudodeficiency (ARSA-PD), hypertension and chronic renal disease in Aboriginal Australians.
复制标题
DOI:
10.1038/s41598-018-29279-9
复制
发表时间:
2018-07-19
影响因子:
4.6
通讯作者:
Blackwell JM
中科院分区:
文献类型:
--
作者:
Tang D;Fakiola M;Syn G;Anderson D;Cordell HJ;Scaman ESH;Davis E;Miles SJ;McLeay T;Jamieson SE;Lassmann T;Blackwell JM
Chronic renal disease (CRD) associated with cardiovascular disease (CVD) and/or type 2 diabetes (T2D) is a significant problem in Aboriginal Australians. Whole exome sequencing data (N = 72) showed enrichment for ClinVar pathogenic variants in gene sets/pathways linking lipoprotein, lipid and glucose metabolism. The top Ingenuity Pathway Analysis canonical pathways were Farsenoid X Receptor and Retinoid Receptor (FXR/RXR; (P = 1.86 × 10−7), Liver X Receptor and Retinoid Receptor (LXR/RXR; P = 2.88 × 10−6), and atherosclerosis signalling (P = 3.80 × 10−6). Top pathways/processes identified using Enrichr included: Reactome 2016 chylomicron-mediated lipid transport (P = 3.55 × 10−7); Wiki 2016 statin (P = 8.29 × 10−8); GO Biological Processes 2017 chylomicron remodelling (P = 1.92 × 10−8). ClinVar arylsulfatase A pseudodeficiency (ARSA-PD) pathogenic variants were common, including the missense variant c.511 G > A (p.Asp171Asn; rs74315466; frequency 0.44) only reported in Polynesians. This variant is in cis with known ARSA-PD 3′ regulatory c.*96 A > G (rs6151429; frequency 0.47) and missense c.1055 A > G (p.Asn352Ser; rs2071421; frequency 0.47) variants. These latter two variants are associated with T2D (risk haplotype GG; odds ratio 2.67; 95% CI 2.32–3.08; P = 2.43 × 10−4) in genome-wide association data (N = 402), but are more strongly associated with quantitative traits (DBP, SBP, ACR, eGFR) for hypertension and renal function in non-diabetic than diabetic subgroups. Traits associated with CVD, CRD and T2D in Aboriginal Australians provide novel insight into function of ARSA-PD variants.
登录
查看更多内容
影响因子:
19.6
作者:
Lew QJ;Jafar TH;Talaei M;Jin A;Chow KY;Yuan JM;Koh WP
通讯作者:
Koh WP
DOI:
10.1126/science.1193032
发表时间:
2010-08-13
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Genovese G;Friedman DJ;Ross MD;Lecordier L;Uzureau P;Freedman BI;Bowden DW;Langefeld CD;Oleksyk TK;Uscinski Knob AL;Bernhardy AJ;Hicks PJ;Nelson GW;Vanhollebeke B;Winkler CA;Kopp JB;Pays E;Pollak MR
通讯作者:
Pollak MR
影响因子:
3.1
作者:
Higasa K;Ogawa A;Terao C;Shimizu M;Kosugi S;Yamada R;Date H;Matsubara H;Matsuda F
通讯作者:
Matsuda F
DOI:
10.5114/aoms.2016.58664
发表时间:
2017-06
期刊:
Archives of medical science : AMS
影响因子:
--
作者:
Hogas S;Bilha SC;Branisteanu D;Hogas M;Gaipov A;Kanbay M;Covic A
通讯作者:
Covic A
DOI:
10.1073/pnas.86.23.9436
发表时间:
1989-12-01
影响因子:
11.1
作者:
GIESELMANN, V;POLTEN, A;VONFIGURA, K
通讯作者:
VONFIGURA, K